Article

A channel-resolved approach coupled with magnet-captured technique for multianalyte chemiluminescent immunoassay.

Key Laboratory of Analytical Chemistry for Life Science (Ministry of Education of China), Department of Chemistry, Nanjing University, Nanjing 210093, China.
Biosensors and Bioelectronics (Impact Factor: 5.44). 06/2008; 23(10):1422-8. DOI: 10.1016/j.bios.2007.11.017
Source: PubMed

ABSTRACT A concept of channel-resolved multianalyte immunoassay (MAIA) and a semi-automated flow-through chemiluminescent (CL) MAIA system coupled with magnet-captured technique were proposed for rapid quantitation of different analytes in a single run. Using alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA) and carcinoma antigen 125 (CA 125) as model analytes. They were firstly incubated in the mixtures of capture antibodies-immobilized paramagnetic microspheres (PMs) and corresponding alkaline phosphatase-labeled antibodies under stir and pumped into three parallel detection channels, the PMs were simultaneously captured by magnet, and the CL signals from the three channels were then sequentially collected with the aid of optical shutters to perform quantitative detection. AFP, CEA and CA 125 could be rapidly assayed in the ranges of 1.0-40microg/l, 0.20-30microg/l and 1.0-50kU/l with the detection limits of 0.60microg/l, 0.080microg/l and 0.70kU/l at 3sigma, respectively. After manual dispensing of specimen and reagents the whole assay process could be completed in 18min. The assay results of clinical serum samples with the proposed method were in acceptable agreement with the reference values. This system, based on the designed channel-resolved strategy and magnet-captured technique provides a semi-automated, reusable, simple, sensitive, rapid and low-cost approach for MAIA without using of expensive array detector.

0 Bookmarks
 · 
121 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this article, we demonstrate the fabrication and simultaneous fluorescent detection of two biomarkers related to lung cancer. Polystyrene microspheres (PSM) were introduced as biomolecular immobilizing carriers and a 96-well filter plate was used as the separation platform. The whole experiment could be effectively carried out in a homogeneous system, as exemplified by the detection of carcinoembryonic antigen (CEA) and neuron specific enolase (NSE). First, two capture antibodies for CEA and NSE were immobilized on the PSM surface. Next, they reacted successively with two antigens and two modified detection antibodies. Finally, these two biomarkers could be recognized by streptavidin-conjugated quantum dots (QD) and goat-anti-FITC conjugated QD with a detection limit of 0.625 ng mL(-1), which was lower than the clinical cut-off level. The protocol showed good precision within 6.36% and good recovery in the range of 90.86-105.02%. Compared with several other assay formats reported previously, our new technique is competitive or even better. Furthermore, the immunosensor was successfully illustrated in 20 serum samples. Overall, this new immunoassay offers a promising alternative for the detection of biomarkers related to cancer diseases, taking advantage of simplicity, specificity, sensitivity and cost-efficiency.
    Analytica chimica acta 07/2011; 698(1-2):44-50. · 4.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this paper, a novel, low-cost electrochemiluminescence (ECL) immunosensor using core-shell Fe3O4-Au magnetic nanoparticles (AuMNPs) as the carriers of the primary antibody of carbohydrate antigen 125 (CA125) was designed. Graphene sheet (GS) with property of good conductivity and large surface area was a captivating candidate to amplify ECL signal. We successively synthesized functionalized GS by loading large amounts of quantum dots (QDs) onto the poly (diallyldimethyl-ammonium chloride) (PDDA) coated graphene sheet (P-GS@QDs) via self-assembly electrostatic reactions, which were used to label secondary antibodies. The ECL immunosensors coupled with a microfluidic strategy exhibited a wide detection range (0.005-50UmL(-1)) and a low detection limit (1.2mUmL(-1)) with the help of an external magnetic field to gather immunosensors. The method was evaluated with clinical serum sample, receiving good correlation with results from commercially available analytical procedure.
    Analytica chimica acta 04/2013; 770:132-9. · 4.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Analytical applications of chemiluminescence detection systems based on magnetic microparticles and nanoparticles (MMP-CL and MNP-CL) have attracted growing interest in research and commercial fields. This article reviews the literature on the analytical applications of MMP-CL and MNP-CL systems, illustrated by different reaction strategies, such as immunoassay and hybridization labels in diverse fields (e.g., clinical and pharmaceutical, environmental or food analysis).
    TrAC Trends in Analytical Chemistry 01/2013; 51:51–70. · 6.35 Impact Factor

Full-text

View
1 Download
Available from